Know Cancer

or
forgot password

Investigate Plaque and Gingival Index


Phase 3
18 Years
65 Years
Not Enrolling
Both
Periodontitis

Thank you

Trial Information

Investigate Plaque and Gingival Index


Inclusion Criteria:



- Type 2 diabetes with poor glycaemic control as evidenced by random blood glucose of
>200mg/dl.

- Minimum of 16 teeth

- Chronic periodontitis as indicated by periodontal probing depths >4mm on at least 6
teeth

Exclusion Criteria:

- Any condition requiring antibiotic cover for dental treatment

- Other serious illness

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Outcome Measure:

HbA1c Levels in Blood

Outcome Description:

Blood is taken from each subject and HbA1c levels were measured at 12 months by Queensland Health Pathology Scientific Services (QHPSS). This test measures the glycated hemoglobin in the blood.

Outcome Time Frame:

12 months

Safety Issue:

No

Principal Investigator

Gregory Seymour, BDS, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Otago University

Authority:

United States: Food and Drug Administration

Study ID:

2004000685

NCT ID:

NCT00762762

Start Date:

March 2006

Completion Date:

December 2008

Related Keywords:

  • Periodontitis
  • Periodontitis

Name

Location